EDGAR Filing Documents for 0001062993-15-002013

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001062993-15-002013

Filing Date

2015-04-16

Accepted

2015-04-16 16:02:26

Documents

Period of Report

2015-04-16

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	form6k.htm	6-K	4546
2	EXHIBIT 99.1	exhibit99-1.htm	EX-99.1	3405
3	EXHIBIT 99.2	exhibit99-2.htm	EX-99.2	5848
4	GRAPHIC	exhibit99-1x1x1.jpg	GRAPHIC	3988
5	GRAPHIC	exhibi1.jpg	GRAPHIC	8830
	Complete submission text file	0001062993-15-002013.txt		32724

Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9

Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627

Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)